Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone after out-of-hospital cardiac arrest
2020-000855-11Phase 2Completed
- Sponsor
- Department of Cardiology, Rigshospitalet
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in cardiac arrest (SCA) comparing Solu-Medrol with Placebo (2 arms). Primary endpoints: Anti-inflammatory effect and Neuroprotective effect. Started Mar 2020; status: completed.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2020-000855-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000855-11.